Tuberculosis Research and Treatment / 2016 / Article / Tab 2

Research Article

Impact of WHO 2010 Guidelines on Antiretroviral Therapy Initiation among Patients with HIV-Associated Tuberculosis in Clinics with and without Onsite HIV Services in the Democratic Republic of Congo

Table 2

Effect of the WHO 2010 guidelines and that of decentralization of HIV services on ART initiation among HIV/TB patients in TB clinics in Kinshasa and Kisangani, Democratic Republic of Congo.

TB typePopulationPeriod beforePR (95% CI)Period afterPR (95% CI)PR 95% CI
EligibleInitiated on ARTEligibleInitiated on ART

KinshasaOnsite ART507401 (79.1)1.58 (1.32, 1.89)795714 (89.8)0.97 (0.93, 1.00)1.14 (1.08, 1.19)
No onsite ART12663 (50.0)1371345 (93.0)11.86 (1.56, 2.22)

KisanganiOnsite ART7653 (69.7)2.10 (1.40, 3.16)152135 (88.8)1.22 (1.09, 1.37)1.27 (1.09, 1.49)
No onsite ART4416 (36.4)1146106 (72.6)12.00 (1.33, 2.99)

Period before and after implementation of guidelines of WHO 2010: January 2012 in Kisangani and March 2012 in Kinshasa. Clinics with onsite (colocated) ART service or without.HIV/TB patients referred for HIV care including ART. Log-binomial model estimates comparing the proportion of HIV/TB patients initiated on ART by type of clinic. Log-binomial model estimates comparing the proportion of HIV/TB patients initiated on ART by period after and before (after period = index). PR: proportion ratio. 95% CI: 95% confidence interval.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.